BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 2003
View Archived Issues
The EP4 agonist Ono-4819 accelerates bone healing in rats
Read More
CGP-41251 demonstrates novel immunosuppressive activity
Read More
Inhibition of p38 MAPK with FR-167653 prevents the onset and progression of arthritis in rats
Read More
D-003 prevents bone loss and reduces bone resorption in ovariectomized rats
Read More
CC-5013 inhibits adhesion molecules and prevents metastasis in an animal model
Read More
Good safety profile for peginterferon alfa-2a in malignant melanoma
Read More
MEDI-522 well tolerated in patients with refractory colorectal cancer
Read More
Pfizer presents promising preclinical data for CP-690550
Read More
Halofuginone efficacy and pharmacokinetic data presented at ASCO
Read More
Evidence of antitumor effects found for endostatin in neuroendocrine tumors
Read More
Once daily NM-3 is well tolerated and has antitumor activity in advanced solid tumors
Read More
ABT-510 is well tolerated and induces antitumor response in cancer patients
Read More
Evaluation of the antiangiogenic effects of chemotherapy using dynamic MRI
Read More
Biogen/Icos LFA-1 collaboration is concluded
Read More
BioSante signs biodefense vaccine CRADA with U.S. Army
Read More
Final phase IIa results from kidney transplant study of ISA-247
Read More
ATL-1101 silences target gene in lab psoriasis studies
Read More
CHF-3381 proceeds to proof-of-concept study
Read More
Four related series of antiviral neuraminidase inhibitors reported by Biota
Read More
New alpha4 integrin antagonists and their use in IBD, asthma, arthritis, etc.
Read More
Novel glycogen phosphorylase inhibitors prepared and tested by JT researchers
Read More
AstraZeneca scientists present new P2X7 receptor antagonists in a recent patent
Read More
New cannabinoid CB2 receptor ligands in early development at Schering-Plough
Read More
New PDE5 inhibitors in Schering-Plough development pipeline
Read More
Compounds able to inhibit HDM2 or MDM2 binding to p53 and their use as antitumor agents
Read More
Inverse agonism of the CB1 receptor increases energy expenditure
Read More
Serotonin 5-HT6 receptor antagonism attenuates food intake and body weight
Read More
HMR-1426: a potent orally active anoretic
Read More